RCRichard J. Crawley

Richard J. Crawley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard J. Crawley has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Measurement of myocardial blood flow in atrial fibrillation using high-resolution, free-breathing in-line quantitative cardiovascular magnetic resonance

    by Richard J. Crawley, Karl-Philipp Kunze, Anmol Kaushal, Xenios Milidonis, Jack Highton, Blanca Domenech-Ximenos, Irum D. Kotadia, Can Karamanli, Nathan C.K. Wong, Robbie Murphy, et al.


  • Cardiac Perfusion MRI

    by Richard Crawley, Amedeo Chiribiri

  • Open Access

    High-resolution free-breathing automated quantitative myocardial perfusion by cardiovascular magnetic resonance for the detection of functionally significant coronary artery disease

    by R Crawley, K P Kunze, X Milidonis, J Highton, S McElroy, S M Frey, D Hoefler, C Karamanli, N C K Wong, S J Backhaus, et al.

    Current assessment of myocardial ischaemia from stress perfusion cardiovascular magnetic resonance (SP-CMR) largely relies on visual interpretation. This study investigated the use of high-resolution free-breathing SP-CMR with automated quantitative mapping in the diagnosis of coronary artery disease (CAD). Diagnostic performance was evaluated against invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurement. Seven hundred and three patients were recruited for SP-CMR using the research sequence at 3 Tesla. Of those receiving ICA within 6 months, 80 patients had either FFR measurement or identification of a chronic total occlusion (CTO) with inducible perfusion defects seen on SP-CMR. Myocardial blood flow (MBF) maps were automatically generated in-line on the scanner following image acquisition at hyperaemic stress and rest, allowing myocardial perfusion reserve (MPR) calculation. Seventy-five coronary vessels assessed by FFR and 28 vessels with CTO were evaluated at both segmental and coronary territory level. Coronary territory stress MBF and MPR were reduced in FFR-positive (≤0.80) regions [median stress MBF: 1.74 (0.90–2.17) mL/min/g; MPR: 1.67 (1.10–1.89)] compared with FFR-negative regions [stress MBF: 2.50 (2.15–2.95) mL/min/g; MPR 2.35 (2.06–2.54) P < 0.001 for both]. Stress MBF ≤ 1.94 mL/min/g and MPR ≤ 1.97 accurately detected FFR-positive CAD on a per-vessel basis (area under the curve: 0.85 and 0.96, respectively; P < 0.001 for both). A novel scanner-integrated high-resolution free-breathing SP-CMR sequence with automated in-line perfusion mapping is presented which accurately detects functionally significant CAD. High-resolution free-breathing stress perfusion cardiovascular magnetic resonance (SP-CMR) with in-line automated quantitative mapping is accurate in the diagnosis of functionally significant coronary artery disease. Diagnostic performance was compared with invasive fractional flow reserve (FFR) with myocardial blood flow (MBF) at hyperaemic stress and myocardial perfusion reserve (MPR) reduced in patients with inducible ischaemia. CTO, chronic total occlusion; AUC, area under the curve.


  • Open Access

    High Prevalence of New Clinically Significant Findings in Patients With Embolic Stroke of Unknown Source Evaluated by Cardiac Magnetic Resonance Imaging

    by Irum D. Kotadia, Robert O'DOwling, Akosua Aboagye, Richard J. Crawley, Neil Bodagh, Ali Gharaviri, Daniel O'HAre, Jose Alonso Solis‐Lemus, Caroline H. Roney, Iain Sim, et al.

    Background: Embolic stroke of unknown source (ESUS) accounts for 1 in 6 ischemic strokes. Current guidelines do not recommend routine cardiac magnetic resonance (CMR) imaging in ESUS, and beyond the identification of cardioembolic sources, there are no data assessing new clinical findings from CMR in ESUS. This study aimed to assess the prevalence of new cardiac and noncardiac findings and to determine their impact on clinical care in patients with ESUS. Methods and Results: In this prospective, multicenter, observational study, CMR imaging was performed within 3 months of ESUS. All scans were reported according to standard clinical practice. A new clinical finding was defined as one not previously identified through prior clinical evaluation. A clinically significant finding was defined as one resulting in further investigation, follow‐up, or treatment. A change in patient care was defined as initiation of medical, interventional, surgical, or palliative care. From 102 patients recruited, 96 underwent CMR imaging. One or more new clinical findings were observed in 59 patients (61%). New findings were clinically significant in 48 (81%) of these patients. Of 40 patients with a new clinically significant cardiac finding, 21 (53%) experienced a change in care (medical therapy, n=15; interventional/surgical procedure, n=6). In 12 patients with a new clinically significant extracardiac finding, 6 (50%) experienced a change in care (medical therapy, n=4; palliative care, n=2). Conclusions: CMR imaging identifies new clinically significant cardiac and noncardiac findings in half of patients with recent ESUS. Advanced cardiovascular screening should be considered in patients with ESUS. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04555538.


  • Open Access

    Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial

    by Sören J. Backhaus, Harun Uzun, Simon F. Rösel, Alexander Schulz, Torben Lange, Richard J. Crawley, Ruben Evertz, Gerd Hasenfuß, Andreas Schuster